Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonproliferative Diabetic Retinopathy”

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05358080
What this trial is testing

Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy

Who this might be right for
Non Proliferative Diabetic Retinopathy
Hanlim Pharm. Co., Ltd. 396
Testing effectiveness (Phase 2)UnknownNCT05393284
What this trial is testing

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
Valo Health, Inc. 114
Not applicableUnknownNCT01759121
What this trial is testing

Safety and Effectiveness Study of 532nm Laser Subthreshold Panretinal Photocoagulation for Severe NPDR

Who this might be right for
Severe Non-proliferative Diabetic Retinopathy
Sun Yat-sen University 84
Testing effectiveness (Phase 2)Study completedNCT05681884
What this trial is testing

Safety and Efficacy of Faricimab in Patients With NPDR

Who this might be right for
Non-Proliferative Diabetic Retinopathy
Greater Houston Retina Research 179
Testing effectiveness (Phase 2)UnknownNCT04782128
What this trial is testing

Evaluation of RC28-E Injection in Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
RemeGen Co., Ltd. 120
Large-scale testing (Phase 3)Study completedNCT01872611
What this trial is testing

Nepafenac Once Daily for Macular Edema - Study 2

Who this might be right for
Non-Proliferative Diabetic RetinopathyCataract
Alcon Research 819
Large-scale testing (Phase 3)Ended earlyNCT00600262
What this trial is testing

Intravitreal Bevacizumab for Diabetic Retinopathy

Who this might be right for
Severe NonproliferativeProliferative Diabetic RetinopathyActive Photocoagulated Diabetic Retinopathy
Asociación para Evitar la Ceguera en México
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07236645
What this trial is testing

Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy (NPDR)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 200
Not applicableStudy completedNCT01646047
What this trial is testing

Diabetes Visual Function Supplement Study

Who this might be right for
Diabetes Mellitus - Type 1Diabetes Mellitus - Type 2Non-proliferative Diabetic Retinopathy
ZeaVision, LLC 70
Large-scale testing (Phase 3)UnknownNCT00908778
What this trial is testing

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Who this might be right for
Diabetic Retinopathy
Vitreoretinal Technologies, Inc. 160
Testing effectiveness (Phase 2)Study completedNCT02062034
What this trial is testing

Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic RetinopathyDiabetes Mellitus Type 2
University of Guadalajara 61
Post-approval studies (Phase 4)Looking for participantsNCT06662994
What this trial is testing

High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy

Who this might be right for
Diabetic Macular Edema (DME)
Retina Consultants of Orange County 15
Large-scale testing (Phase 3)Study completedNCT01853072
What this trial is testing

Nepafenac Once Daily for Macular Edema - Study 1

Who this might be right for
Non-Proliferative Diabetic RetinopathyCataract
Alcon Research 881
Large-scale testing (Phase 3)Ended earlyNCT00248131
What this trial is testing

Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis Pharmaceuticals 260
Not applicableWithdrawnNCT02309502
What this trial is testing

Panretinal Photo-stimulation in Proliferative Diabetic Retinopathy

Who this might be right for
Severe Non-proliferative Diabetic Retinopathy
Manchester University NHS Foundation Trust
Large-scale testing (Phase 3)Ended earlyNCT00248157
What this trial is testing

Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
Novartis Pharmaceuticals 105
Post-approval studies (Phase 4)UnknownNCT01921192
What this trial is testing

Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy

Who this might be right for
Non Proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
University of Catania 160
Not applicableUnknownNCT03863535
What this trial is testing

PRP vs PRP+IVC for Severe nPDR

Who this might be right for
Severe Nonproliferative Diabetic RetinopathyDiabetic RetinopathyDiabete Mellitus
Ruijin Hospital 40
Not applicableStudy completedNCT01625598
What this trial is testing

Computer Detection of Diabetic Retinopathy Compared to Clinical Examination

Who this might be right for
Diabetic Retinopathy
Digital Diagnostics, Inc. 600
Large-scale testing (Phase 3)UnknownNCT02388984
What this trial is testing

Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy

Who this might be right for
Non-proliferative Diabetic Retinopathy
Tasly Pharmaceuticals, Inc. 480
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation